HomeProductsKey IntermediatesProstate Cancer Drug Abiraterone CAS 154229-19-3

Prostate Cancer Drug Abiraterone CAS 154229-19-3

$5 - 10 /Gram
10 /Gram (Min. Order)
Payment Type:
T/T,Paypal
Incoterm:
FOB
Min. Order:
10 Gram
Transportation:
Land,Air,Express,Ocean
Port:
Shanghai,Shenzhen,Guangzhou
Share:
Chat Now
  • Product Description
Overview
Product Attributes

BrandRhine

GradePhamaceutical Grade

Place Of OriginChina

Test MethodHPLC UV COA

Specification10g:vial/bag

PackageBottles, foil bags

TrademarkRHINE

Sec-HPLC99.5%

Molecular FormulaC24H31NO

MW349.518

Cas154229-19-3

Supply Ability & Additional Information

PackagingFoil bag /bottle

Productivity500 grams per month

TransportationLand,Air,Express,Ocean

Place of Originchina

Supply Ability500grams/month

CertificateN/A

HS Code2934993000

PortShanghai,Shenzhen,Guangzhou

Payment TypeT/T,Paypal

IncotermFOB

Packaging & Delivery
Selling Units:
Gram
Package Type:
Foil bag /bottle
Product Name:Abiraterone CAS:154229-19-3 MF:C24H31NO MW:349.51 Specification:98% Abiraterone acetate, the active ingredient of ZYTIGA is the acetyl ester of abiraterone. Abiraterone is an inhibitor of CYP17 (17α-hydroxylase/C17,20-lyase). Each ZYTIGA tablet contains 250 mg of abiraterone acetate. Abiraterone acetate is designated chemically as (3β)-17-(3-pyridinyl)androsta-5,16-dien-3-yl acetate Abiraterone acetate is a white to off-white, non-hygroscopic, crystalline powder....

Product Categories : Key Intermediates

Email to this supplier
  • *Subject:
  • *To:
    Ms. Caroline
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
Send Inquiry
*
*

HomeProductsKey IntermediatesProstate Cancer Drug Abiraterone CAS 154229-19-3
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send